Waters Corporation filed an 8-K press release on October 28, 2026, announcing the launch of AI-Powered Peak Integration as a new premium subscription capability within its Empower Software chromatography data system.

Key Highlights

  • New capability launched: AI-Powered Peak Integration is now available as a premium tier subscription feature within Empower Software, according to the filing.
  • 95% reduction in manual interventions: A pilot with a large pharmaceutical customer reviewing 400 chromatograms reduced manual interventions from 90 to 4, the company disclosed.
  • 72% lower user-to-user variability: User testing showed a 72% reduction in user-to-user variability and 50% faster review, per the filing.
  • 76% greater accuracy: The company reported 76% greater accuracy as part of the capability's performance data.
  • Early access begins December 2026: Waters is enrolling customers now for early access beginning in December 2026, with validated, compliant deployment to follow in mid-2027, according to the filing.
  • Built on prior AI foundation: The release follows AI/ML Anomaly Detection, which was launched in Empower Software in February 2025, the filing noted.

Waters Expands Empower Software AI Portfolio With Peak Integration Capability

Waters Corporation (NYSE:WAT) announced on October 28, 2026 that it is adding AI-Powered Peak Integration to its Empower Software platform, which the company described as "the chromatography data system of record for regulated laboratories worldwide." According to the filing, Empower Software serves approximately 500,000 users and supports "the release of over 80% of medicines globally." The new capability is offered as a premium subscription tier, adding to a growing set of AI and machine learning features that Waters said it is building directly into the platform.

The filing states that manual peak integration is "the largest source of variability in chromatographic results and one of the most time-consuming steps in data review." The AI/ML-powered capability automates this step using models trained on each laboratory's own data, removing noise peaks, combining high molecular weight peaks, and editing baselines. The filing cited a pilot with a large pharmaceutical customer in which side-by-side review of 400 chromatograms reduced manual interventions from 90 under current practice to 4, representing a 95% reduction. Additional user testing cited in the filing showed 50% faster review and 72% lower user-to-user variability.

The company stated that the capability operates inside the validated environment where customer data already resides, with "no compromise to integrity, traceability, or compliance." Tina Wu, Senior Vice President, Waters Analytical Sciences, Waters Corporation, was quoted in the filing as saying the approach is "a central pillar of how we are advancing Empower Software as AI transforms the laboratory." The filing also noted that Waters is collaborating with large pharmaceutical customers and academic institutions on AI-enabled research, development, and QA/QC capabilities. The pilot data cited is described as a Waters internal study from 2025, and customer evaluation data is from the Waters Immerse Research Lab in 2026, both on file with Waters Corporation.

What Was Disclosed

Waters Corporation disclosed the launch of AI-Powered Peak Integration for Empower Software, a premium subscription capability with early access starting December 2026 and validated deployment targeted for mid-2027, supported by pilot data showing significant reductions in manual interventions and variability.